IDEXX Laboratories Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
07/31

DJ IDEXX Laboratories Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of IDEXX Laboratories Inc. $(IDXX)$ slid 1.93% to $558.80 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.66% to 7,437.63 and the Dow Jones Industrial Average rising 1.19% to 52,208.06.

The stock's fall snapped a four-day winning streak.

IDEXX Laboratories Inc. closed 27.43% short of its 52-week high of $769.98, which the company achieved on November 26th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 3.66% to $255.82, Medtronic PLC $(MDT)$ fell 2.09% to $85.71, and Boston Scientific Corp. $(BSX)$ fell 0.09% to $46.00.

Trading volume (513,079) remained 127,618 below its 50-day average volume of 640,697.

Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026.

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10